Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Feb;69(1):30-40.
doi: 10.1002/bab.2076. Epub 2021 Jan 21.

A review of COVID-19 vaccines and major considerations for diabetic patients

Saber Soltani  1   2 , Milad Zandi  1   2 , Parisa Shiri Aghbash  3 , Masoud Rezaei  4 , Nader Mohammadzadeh  5 , Alireza Afsharifar  6 , Vahdat Poortahmasebi  3
Affiliations
Review

A review of COVID-19 vaccines and major considerations for diabetic patients

Saber Soltani et al. Biotechnol Appl Biochem. 2022 Feb.

Abstract

The necessity and impact of SARS-CoV2 on the world's health have led to developing and producing practical and useful vaccines for this deadly respiratory virus. Since April 2020, a vaccine for the virus has been developed. Given that comorbidities such as diabetes, hypertension, and cardiovascular disease are more prone to viruses and the risk of infection, vaccines should be designed to protect against high-risk respiratory illnesses. Including SARS, MERS, influenza, and the SARS-CoV-2 provide a safe immune response. Here, we review the information and studies that have been done to help develop strategies and perspectives for producing a safe and ideal vaccine to prevent COVID-19 in normal people, especially at high-risk groups such as diabetes patients.

Keywords: COVID-19; Diabetes; SARS-CoV-2; Vaccine.

PubMed Disclaimer

References

    1. Ahmed Syed Faraz, Quadeer Ahmed A., McKay Matthew R. Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies. Viruses. 2020;12: 3:254. https://doi.org/10.3390/v12030254.
    1. Fani Mona, Zandi Milad, Soltani Saber, Abbasi Samaneh. Future developments in biosensors for field-ready SARS-CoV-2 virus diagnostics. Biotechnology and Applied Biochemistry. 2020. https://doi.org/10.1002/bab.2033.
    1. The hemagglutinin-esterase gene in human coronaviruses SARS-CoV-2, HKU1 and OC43. Virus Research. 2006;24: 12:17-37. https://www.europeanreview.org/article/21630.
    1. Padron-Regalado Eriko. Vaccines for SARS-CoV-2: Lessons from Other Coronavirus Strains. Infectious Diseases and Therapy. 2020;9: 2:255-274. https://doi.org/10.1007/s40121-020-00300-x.
    1. Lu Roujian, Zhao Xiang, Li Juan, Niu Peihua, Yang Bo, Wu Honglong, Wang Wenling, Song Hao, Huang Baoying, Zhu Na, Bi Yuhai, Ma Xuejun, Zhan Faxian, Wang Liang, Hu Tao, Zhou Hong, Hu Zhenhong, Zhou Weimin, Zhao Li, Chen Jing, Meng Yao, Wang Ji, Lin Yang, Yuan Jianying, Xie Zhihao, Ma Jinmin, Liu William J, Wang Dayan, Xu Wenbo, Holmes Edward C, Gao George F, Wu Guizhen, Chen Weijun, Shi Weifeng, Tan Wenjie. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. The Lancet. 2020;395: 10224:565-574. https://doi.org/10.1016/s0140-6736(20)30251-8.

LinkOut - more resources